212 related articles for article (PubMed ID: 34326844)
1. Impaired Priming of SARS-CoV-2-Specific Naive CD8
Gallerani E; Proietto D; Dallan B; Campagnaro M; Pacifico S; Albanese V; Marzola E; Marconi P; Caputo A; Appay V; Gavioli R; Nicoli F
Front Immunol; 2021; 12():693054. PubMed ID: 34326844
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
[TBL] [Abstract][Full Text] [Related]
3. CD8
Nguyen THO; Rowntree LC; Petersen J; Chua BY; Hensen L; Kedzierski L; van de Sandt CE; Chaurasia P; Tan HX; Habel JR; Zhang W; Allen LF; Earnest L; Mak KY; Juno JA; Wragg K; Mordant FL; Amanat F; Krammer F; Mifsud NA; Doolan DL; Flanagan KL; Sonda S; Kaur J; Wakim LM; Westall GP; James F; Mouhtouris E; Gordon CL; Holmes NE; Smibert OC; Trubiano JA; Cheng AC; Harcourt P; Clifton P; Crawford JC; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Torresi J; Kedzierska K
Immunity; 2021 May; 54(5):1066-1082.e5. PubMed ID: 33951417
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8
Saini SK; Hersby DS; Tamhane T; Povlsen HR; Amaya Hernandez SP; Nielsen M; Gang AO; Hadrup SR
Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33853928
[TBL] [Abstract][Full Text] [Related]
5. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
Front Immunol; 2021; 12():684014. PubMed ID: 34194438
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8
Agerer B; Koblischke M; Gudipati V; Montaño-Gutierrez LF; Smyth M; Popa A; Genger JW; Endler L; Florian DM; Mühlgrabner V; Graninger M; Aberle SW; Husa AM; Shaw LE; Lercher A; Gattinger P; Torralba-Gombau R; Trapin D; Penz T; Barreca D; Fae I; Wenda S; Traugott M; Walder G; Pickl WF; Thiel V; Allerberger F; Stockinger H; Puchhammer-Stöckl E; Weninger W; Fischer G; Hoepler W; Pawelka E; Zoufaly A; Valenta R; Bock C; Paster W; Geyeregger R; Farlik M; Halbritter F; Huppa JB; Aberle JH; Bergthaler A
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33664060
[TBL] [Abstract][Full Text] [Related]
7. PD-1-Expressing SARS-CoV-2-Specific CD8
Rha MS; Jeong HW; Ko JH; Choi SJ; Seo IH; Lee JS; Sa M; Kim AR; Joo EJ; Ahn JY; Kim JH; Song KH; Kim ES; Oh DH; Ahn MY; Choi HK; Jeon JH; Choi JP; Kim HB; Kim YK; Park SH; Choi WS; Choi JY; Peck KR; Shin EC
Immunity; 2021 Jan; 54(1):44-52.e3. PubMed ID: 33338412
[TBL] [Abstract][Full Text] [Related]
8. Detection of IFNγ-Secreting CD4
Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
[TBL] [Abstract][Full Text] [Related]
9. Suboptimal SARS-CoV-2-specific CD8
Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.
Shomuradova AS; Vagida MS; Sheetikov SA; Zornikova KV; Kiryukhin D; Titov A; Peshkova IO; Khmelevskaya A; Dianov DV; Malasheva M; Shmelev A; Serdyuk Y; Bagaev DV; Pivnyuk A; Shcherbinin DS; Maleeva AV; Shakirova NT; Pilunov A; Malko DB; Khamaganova EG; Biderman B; Ivanov A; Shugay M; Efimov GA
Immunity; 2020 Dec; 53(6):1245-1257.e5. PubMed ID: 33326767
[TBL] [Abstract][Full Text] [Related]
11. Identification of HLA-A2 restricted CD8
Deng J; Pan J; Qiu M; Mao L; Wang Z; Zhu G; Gao L; Su J; Hu Y; Luo OJ; Chen G; Wang P
J Leukoc Biol; 2021 Dec; 110(6):1171-1180. PubMed ID: 34231935
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
Schmidt KG; Nganou-Makamdop K; Tenbusch M; El Kenz B; Maier C; Lapuente D; Überla K; Spriewald B; Bergmann S; Harrer EG; Harrer T
Front Immunol; 2021; 12():627568. PubMed ID: 33995351
[TBL] [Abstract][Full Text] [Related]
13. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients.
Ni L; Cheng ML; Feng Y; Zhao H; Liu J; Ye F; Ye Q; Zhu G; Li X; Wang P; Shao J; Deng YQ; Wei P; Chen F; Qin CF; Wang G; Li F; Zeng H; Dong C
Front Immunol; 2021; 12():603563. PubMed ID: 33603759
[TBL] [Abstract][Full Text] [Related]
14. CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.
Guo E; Guo H
PLoS One; 2020; 15(12):e0239566. PubMed ID: 33301503
[TBL] [Abstract][Full Text] [Related]
15. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
Front Immunol; 2020; 11():596684. PubMed ID: 33362779
[TBL] [Abstract][Full Text] [Related]
16. Profiling CD8
Zhang H; Deng S; Ren L; Zheng P; Hu X; Jin T; Tan X
Cell Rep; 2021 Sep; 36(11):109708. PubMed ID: 34506741
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of highly cytotoxic CD8
Wagner KI; Mateyka LM; Jarosch S; Grass V; Weber S; Schober K; Hammel M; Burrell T; Kalali B; Poppert H; Beyer H; Schambeck S; Holdenrieder S; Strötges-Achatz A; Haselmann V; Neumaier M; Erber J; Priller A; Yazici S; Roggendorf H; Odendahl M; Tonn T; Dick A; Witter K; Mijočević H; Protzer U; Knolle PA; Pichlmair A; Crowell CS; Gerhard M; D'Ippolito E; Busch DH
Cell Rep; 2022 Jan; 38(2):110214. PubMed ID: 34968416
[TBL] [Abstract][Full Text] [Related]
18. IFN-γ
Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
[TBL] [Abstract][Full Text] [Related]
19. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
Reche PA
Front Immunol; 2020; 11():586984. PubMed ID: 33178220
[TBL] [Abstract][Full Text] [Related]
20. A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4
Zelba H; Worbs D; Harter J; Pieper N; Kyzirakos-Feger C; Kayser S; Seibold M; Bartsch O; Ködding J; Biskup S
J Immunol; 2021 Feb; 206(3):580-587. PubMed ID: 33298615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]